| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/28/2011 | US7968544 Modulators of toll-like receptor 7 |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968518 Use of modified cyclosporins for the treatment of HCV disorders |
| 06/28/2011 | US7968332 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 06/28/2011 | US7968297 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders |
| 06/28/2011 | US7968103 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 06/28/2011 | US7968100 Surface proteins from coagulase-negative staphylococci and Staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 06/28/2011 | CA2479039C 2,2-bis(hydroxymethyl)cyclopropylidenemethyl -purines and -pyrimidines as antiviral agents |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2382497C Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/28/2011 | CA2380305C Streptogramin derivatives, production thereof and compositions containing the same |
| 06/28/2011 | CA2322008C 2'-fluoronucleosides |
| 06/23/2011 | WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | WO2011075607A1 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | WO2011075379A1 Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
| 06/23/2011 | WO2011075052A1 Novel 3´-deoxy-3´-methylidene- -l-nucleosides |
| 06/23/2011 | WO2011074782A2 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine |
| 06/23/2011 | WO2011074608A1 Prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011074607A1 Triterpene derivative, and prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011073489A1 Use of raltegravir and derivatives for producing medicaments for the treatment of infections caused by the herpes virus |
| 06/23/2011 | WO2011073479A1 Use of seconeolitsine and n-methyl-seconeolitsine for the manufacture of medicaments |
| 06/23/2011 | WO2011073419A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance |
| 06/23/2011 | WO2011073395A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | WO2011073392A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | WO2011073378A1 Tricyclic antibiotics |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011073114A1 Heterocyclic antiviral compounds |
| 06/23/2011 | WO2011073112A2 Mannose derivatives as antagonists of bacterial adhesion |
| 06/23/2011 | WO2011072487A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/23/2011 | WO2011072474A1 Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof |
| 06/23/2011 | WO2011072370A1 Hcv combination therapy |
| 06/23/2011 | WO2011072336A1 Antiviral agents |
| 06/23/2011 | WO2011053172A3 Drug for treating hiv/aids infections and the loss of sexual desire, method for preparing same and use thereof. |
| 06/23/2011 | WO2011050994A3 Closthioamides |
| 06/23/2011 | WO2011030166A9 The use of lipid emulsions for binding hepatitis c virus |
| 06/23/2011 | WO2011022508A3 Substituted benzoazepines as toll-like receptor modulators |
| 06/23/2011 | WO2011019839A3 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 06/23/2011 | WO2011001165A3 Anti-acne formulations containing a dialkyl sulphosuccinate and salicylic acid |
| 06/23/2011 | WO2010144348A3 Reduction of antibiotic activity or concentration in biological samples using molecularly imprinted polymers |
| 06/23/2011 | WO2010132765A3 Antibacterial aminoglycoside analogs |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152383 Compositions comprising benzyl alcohol derivatives and further antimicrobial active compounds |
| 06/23/2011 | US20110152379 Composition for control of aging and/or extension of life, containing dapsone as active ingredient |
| 06/23/2011 | US20110152356 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 06/23/2011 | US20110152346 Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids |
| 06/23/2011 | US20110152337 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 06/23/2011 | US20110152333 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 06/23/2011 | US20110152325 Carboxamide compounds and their use as calpain inhibitors iv |
| 06/23/2011 | US20110152311 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 06/23/2011 | US20110152307 Ophthalmic composition comprising ascomycin |
| 06/23/2011 | US20110152305 Films and particles |
| 06/23/2011 | US20110152303 Chemical Compounds |
| 06/23/2011 | US20110152302 Novel dicyclanil-based shelf stable aqueous suspension and non-aqueous solution pour-on and spray-on formulations useful for the prevention and treatment of insect infestation in animals |
| 06/23/2011 | US20110152301 Compounds that Inhibit HIV Particle Formation |
| 06/23/2011 | US20110152285 Pyrrole antifungal agents |
| 06/23/2011 | US20110152279 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 06/23/2011 | US20110152265 Carboxamide compounds and their use as calpain inhibitors v |
| 06/23/2011 | US20110152263 Composition and method for inhibiting norovirus infection |
| 06/23/2011 | US20110152251 Compounds for modulating tlr2 |
| 06/23/2011 | US20110152246 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/23/2011 | US20110152239 10a-azalide compound having 4-membered ring structure |
| 06/23/2011 | US20110152237 Chemical Compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152231 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms |
| 06/23/2011 | US20110152229 Betulinic acid derivatives as anti-hiv agents |
| 06/23/2011 | US20110152228 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase |
| 06/23/2011 | US20110152225 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |
| 06/23/2011 | US20110152216 Anaesthetic composition |
| 06/23/2011 | US20110152212 Aqueous Formulations |
| 06/23/2011 | US20110152211 Methods and formulations for reducing amphotericin b treatment side effects |
| 06/23/2011 | US20110152207 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/23/2011 | US20110152179 Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA |
| 06/23/2011 | US20110152178 Prophylactic or therapeutic agent for influenza virus infection |
| 06/23/2011 | US20110152177 Functional Feed Composition |
| 06/23/2011 | US20110152176 Agr-mediated inhibition and dispersal of biofilms |
| 06/23/2011 | US20110152175 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 06/23/2011 | US20110152170 Use of Procalcitonin (PCT) in Risk Stratification and Prognosis of Patients with a Primary, Non-Infectious Disease |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110152083 Network copolymer crosslinked compositions and products comprising the same |
| 06/23/2011 | US20110151025 Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections |
| 06/23/2011 | US20110151015 Immunomodulator particles and methods of treating |
| 06/23/2011 | US20110150997 Elvucitabine pharmaceutical compositions |
| 06/23/2011 | US20110150972 Medical devices having improved performance |
| 06/23/2011 | US20110150963 Bioactive antibacterial bone graft materials |
| 06/23/2011 | US20110150955 Products and Methods for Reducing Malodor from the Pudendum |
| 06/23/2011 | US20110150944 Structured triglycerides and emulsions comprising same |
| 06/23/2011 | US20110150943 Adhesive for medical applications and means for haemostasis |
| 06/23/2011 | US20110150941 Epithelial delivery |
| 06/23/2011 | US20110150940 Dry powder compositions and systems for poultry vaccination |
| 06/23/2011 | US20110150933 Cattle vaccines |
| 06/23/2011 | US20110150932 Constructing a DNA Chimera for Vaccine Development Against Leishmaniasis and Tuberculosis |
| 06/23/2011 | US20110150929 SARS vaccine compositions and methods of making and using them |
| 06/23/2011 | US20110150928 Unique avian reoviridae |
| 06/23/2011 | US20110150927 Stabilisation of Viral Microparticles |
| 06/23/2011 | US20110150925 Cell-based systems for producing influenza vaccines |
| 06/23/2011 | US20110150923 Mucosal meningococcal vaccines |
| 06/23/2011 | US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/23/2011 | US20110150918 Treatment of microbial infections |